Colon Cancer
829
116
163
371
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
101 trials with published results (12%)
Research Maturity
371 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
66 terminated out of 829 trials
84.9%
-1.7% vs benchmark
7%
61 trials in Phase 3/4
27%
101 of 371 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 371 completed trials
Clinical Trials (829)
Distance-Based Exercise to Preserve Function and Prevent Disability
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
PRE-ISPY Phase I/II Oncology Platform Program
ONS USE IN COLON CANCER
A Study of PHN-012 in Patients With Advanced Solid Tumors
Genomic Services Research Program
RCT of Mobile Apps & FitBit v. Usual Care
Collection of Blood From Patients With Cancer
ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy
The Role of Total Abdominal Autonomic Nerve Preservation During the Resection of Right/Left Colon Cancer: Prospective Clinical Trial
Endogenous Mechanisms of Inactivation of the Endothelium Tumor